CTV's Fall 2014 Executives in Residence; farewell to Donna See
View this email in your browser

Welcome to CTV’s Fall 2014 Executives-in-Residence; Farewell to Donna See

Dear Colleagues,

Please join me in extending a warm welcome to CTV’s latest Executives-in-Residence for Fall 2014! We’ve got a great group of XIRs this Fall, including:

  • Bob Sheehy, former CEO of United Healthcare
  • George Cigale, founder and CEO of Tutor.com (acquired by IAC)
  • Bill Reinisch, Venture Partner at Paladin Capital
  • Rick D’Augustine, serial medical device entrepreneur and investor
  • Francis Lee, healthcare strategist for McKinsey and Gerson Lehrman.
  • Brian Phillips, formerly of IBM and TechnoServe (returning for another term)

If you are a Columbia student, staff member, or researcher and would like to meet with one of our XIRs to discuss your project or start-up, please email us at techventures@columbia.edu. Our XIRs are standing by to talk with you. 

More broadly, if you are interested in the patenting and licensing of early-stage innovation, as well as the role university research plays in this arena, please join me on October 21st or October 22nd for a public discussion on that topic. For more details and to RSVP, please click here.

Last but not least… sadly for us (but great for her!), we are bidding farewell to the incomparable Donna See, CTV’s Director of Licensing for Morningside. After 11 years of outstanding service to the University, Donna has accepted an exciting new role with Allied Minds (LSE:ALM), a public company dedicated to investing in, launching, and operating companies based on U.S. university and federal lab innovation. Columbia has been a university partner of Allied Minds since 2009. Donna will be sourcing and incubating opportunities for Allied Minds’ university portfolio (both life and physical sciences), including for their recently-announced Allied-Bristol Life Sciences, a joint venture between Allied Minds and Bristol-Myers Squibb. Donna, we wish you the best of luck with your new adventure!  

Best wishes,

Orin Herskowitz
Executive Director, CTV
VP for Intellectual Property & Technology Transfer

Search All Available Technologies

Upcoming Events & Deadlines

Patenting & Licensing of Early-Stage University Technology - Morningside

Orin Herskowitz, Executive Director at CTV and Columbia's VP for Intellectual Property and Technology Transfer will lead this discussion. 
Patenting & Licensing of Early-Stage University Technology - Medical Center

Orin Herskowitz, Executive Director at CTV and Columbia's VP for Intellectual Property and Technology Transfer will lead this discussion. 
Kerafast Lunch & Learn

Please join Amelia Gibson, the Director of Business Development at Kerafast, for a short presentation and complimentary lunch. 
Venture Capital Perspective: Medical Devices & Digital Health

Join us for a lively discussion and Q&A with Dr. Lee Wrubel of Foundation Medical Partners, covering venture capital perspectives on the evolution of the start-up landscape in medical devices and digital health.  
Columbia-Coulter Translational Research Partnership

Through the Columbia-Coulter Translational Research Partnership, selected teams receive funding and guidance to advance promising biomedical technology ideas from conception to proof-of-concept.  
See All Upcoming Events & Deadlines

Latest News & Videos

VIDEO: Patents 101

CTV Events Watch Jeffrey M. Sears, PhD, Chief Patent Counsel for Columbia University, present a patent law primer focusing on what you need to know to preserve patent protection for your inventions.
Tumor Segmentation Software Receives 510k Clearance From FDA

NEWSWISE Columbia University’s imaging software that facilitates 3-D lung tumor segmentation, licensed to Varian Medical Systems, has been incorporated into the Smart Segmentation® module of Varian’s Eclipse™ treatment planning system and has received FDA 510k clearance.
Celebrating 86 Years of a Medical Center

CUMC NEWSROOM In October 1928—86 years ago this month—Columbia-Presbyterian Medical Center, a unique collaboration that started with the partnership of Columbia University College of Physicians & Surgeons and Presbyterian Hospital, was dedicated.

Available Technologies

Automated Natural Language Processing Tool Uses Machine Learning to Identify Quoted Speech in Literary Narratives | Learn more

Development of a Serological Assay to Predict Graft Loss in Kidney Transplant Candidates | Learn more

Method for Culturing Patient-Derived Cancer Cells Expedites Treatment Decisions for Bladder Cancer | Learn more

Passive Low Noise Amplifier Achieves Linear Signal Amplification and Complete Noise Cancellation for High Performance Integrated Circuit Applications | Learn more
Using Android Devices to Run Mobile Apps Designed for iOS | Learn more

Search All Available Technologies
Copyright © 2014 Columbia Technology Ventures, All rights reserved.

unsubscribe from this list    update subscription preferences